Back to dashboard
MedicaidCoverageLow impact

Newsletter Vol. 14, No. 50

New Jersey Medicaid·NJ·Pharmacy
Effective date
Jun 3, 2004
We identified it
Jun 20, 2026
Days to comply

Summary

New Jersey has added four pharmaceutical manufacturers to the PAAD (Pharmaceutical Assistance to the Aged and Disabled) Drug Rebate Program, expanding coverage options for eligible patients. The additions include Imiren Pharmaceuticals, Colorado Biolabs, Baxter Healthcare Corporation, and Presutti Laboratories with effective dates ranging from June to August 2004.

Action Required

Action needed
No immediate action required for billing teams. This is an informational update about manufacturer participation in New Jersey's PAAD program that may affect prescription coverage for eligible aged and disabled patients. Billing staff should be aware that these manufacturers' products may now be covered under PAAD for qualifying patients.